Back to Search
Start Over
Phase II Study of Panitumumab in RAS Wild‐Type Metastatic Adenocarcinoma of Small Bowel or Ampulla of Vater.
- Source :
- Oncologist; Mar2018, Vol. 23 Issue 3, p277-e26, 7p, 9 Charts, 2 Graphs
- Publication Year :
- 2018
-
Abstract
- <i>Copyright of Oncologist is the property of Oxford University Press / USA and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.)
- Subjects :
- THERAPEUTIC use of monoclonal antibodies
ADENOCARCINOMA
CLINICAL trials
DRUG toxicity
EPIDERMAL growth factor
SMALL intestine
INTESTINAL tumors
INTRAVENOUS therapy
METASTASIS
MONOCLONAL antibodies
GENETIC mutation
ONCOGENES
JEJUNUM tumors
DUODENAL tumors
FUTILE medical care
TREATMENT effectiveness
DISEASE progression
ILEUM
ACNEIFORM eruptions
CHEMICAL inhibitors
PROGNOSIS
TUMORS
Subjects
Details
- Language :
- English
- ISSN :
- 10837159
- Volume :
- 23
- Issue :
- 3
- Database :
- Complementary Index
- Journal :
- Oncologist
- Publication Type :
- Academic Journal
- Accession number :
- 128398724
- Full Text :
- https://doi.org/10.1634/theoncologist.2017-0568